文献速递类风湿关节炎其他结缔组织病

类风湿关节炎备孕女性抗SSA/SSB抗体低患病率研究

Low prevalence of anti-SSA (anti-Ro) and anti-SSB (anti-La) autoantibodies in female patients with rheumatoid arthritis with a wish to conceive.
PubMed 文献 · RMD Open · 2021-01-01

该研究基于PARA和PreCARA两个大型类风湿关节炎(RA)妊娠队列,发现647例备孕或妊娠RA患者中抗SSA和/或抗SSB抗体阳性者仅26例,抗SSA阳性率为3.9%,抗SSB为1.1%,且未观察到新生儿狼疮或先天性心脏传导阻滞病例;法国国家登记中SSA相关先天性心脏传导阻滞母亲RA患病率为1.5%。结论认为RA备孕患者中抗SSA/SSB患病率低,尤其RF阴性者,当前普遍检测的建议应重新考虑。

要点

  • RA备孕或妊娠患者抗SSA/SSB抗体阳性率低,抗SSA为3.9%,抗SSB为1.1%。
  • RF阳性患者抗SSA/SSB患病率高于RF阴性患者(5.1% vs 1.6%,p=0.04)。
  • 本队列未观察到新生儿狼疮或先天性心脏传导阻滞病例。

核心结论

  • RA备孕患者中抗SSA和抗SSB抗体患病率低,尤其RF阴性患者,当前建议普遍检测这两项抗体的策略应重新考虑。

研究设计与样本

  • 研究纳入PARA和PreCARA两个大型RA妊娠队列共647例备孕或妊娠患者,并分析法国国家新生儿狼疮综合征和先天性心脏传导阻滞登记中母亲RA的诊断患病率。

主要发现

  • 647例中26例可检测到抗SSA和/或抗SSB,抗SSA阳性25例(3.9%),抗SSB阳性7例(1.1%)。
  • RF阳性患者抗SSA和/或抗SSB患病率高于RF阴性患者(5.1% vs 1.6%,p=0.04)。
  • 本队列后代中未观察到先天性心脏传导阻滞和/或新生儿狼疮综合征病例。
  • 法国国家登记中,SSA相关先天性心脏传导阻滞母亲RA患病率为1.5%。

关键数值与推荐

  • 抗SSA阳性率3.9%(25/647),抗SSB阳性率1.1%(7/647),抗SSA和/或抗SSB阳性26/647。
  • RF阳性与RF阴性患者抗SSA和/或抗SSB患病率比较为5.1% vs 1.6%(p=0.04)。
  • 法国国家登记中SSA相关先天性心脏传导阻滞母亲RA患病率为1.5%。

临床怎么用

  • 对于RA备孕女性,尤其RF阴性者,可基于低患病率证据重新评估常规检测抗SSA/SSB的必要性。
  • RF阳性RA备孕患者抗SSA/SSB患病率相对较高,仍应关注抗体检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Guidelines advise to test for anti-Sjögren's-syndrome-related antigen A (anti-SSA) and anti-Sjögren's-syndrome-related antigen B (anti-SSB) antibodies in all patients with rheumatoid arthritis (RA) who wish to conceive. Our objective was to determine the prevalence and titres of anti-SSA and anti-SSB autoantibodies in patients with RA with a wish to conceive or pregnant. METHODS: Patients were derived from two large cohorts on RA and pregnancy (PARA cohort and PreCARA cohort). In addition, to determine the clinical relevance of searching for anti-SSA and anti-SSB in patients with RA, we studied the prevalence of the maternal diagnosis of RA in the French national registry of neonatal lupus syndrome (NLS) and congenital heart block (CHB). RESULTS: 26 out of 647 patients with RA had detectable anti-SSA and/or anti-SSB. Anti-SSA was detected in 25 out of 647 patients (3.9%) (Ro-52, n=17; Ro-60, n=19), anti-SSB in 7 out of 647 (1.1%). Thirteen women had a titre of >240 units/mL of anti-SSA antibodies. The prevalence of anti-SSA and/or anti-SSB was higher in rheumatoid factor (RF)-positive patients compared with RF-negative patients (5.1% vs 1.6%, p=0.04). No cases of CHB and/or NLS in the offspring were observed. In the French national register, the prevalence of RA in mothers with SSA related CHB was 1.5%. CONCLUSION: Anti-SSA and anti-SSB have a low prevalence in patients with RA who wish to conceive. Especially for RF-negative patients, the current advise to test for anti-SSA and anti-SSB should be reconsidered.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Smeele HTW, Schreurs MWJ, Costedoat-Chalumeau N, et al. Low prevalence of anti-SSA (anti-Ro) and anti-SSB (anti-La) autoantibodies in female patients with rheumatoid arthritis with a wish to conceive. RMD Open. 2021. PMID: 34244382. doi:10.1136/rmdopen-2021-001727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。